The proportion of stage I/II ovarian cancers was higher in the screened group (67%) than in the control group (44%), but this difference did not reach statistical significance (p=0.116).
1
0.1160
0.1160
The proportion of stage I/II ovarian cancers was higher in the screened group (67%) than in the control group (44%), but this difference did not reach statistical significance (p=0.116).